PAGB members can access detailed regulatory intelligence on OTC medicines (below), self care medical devices and food supplements when logged in to this website (registration for PAGB members and associate members only). This information is automatically emailed on a weekly basis to PAGB members who subscribe to our Regulatory Intelligence newsletter. Contact firstname.lastname@example.org for more information about subscribing to this newsletter.
PAGB’s regulatory advice for members on Covid-19 issues is being posted to a dedicated section of our website, which is restricted to members only (log-in required). This includes a comprehensive blog of Covid-19-related regulatory information and policy announcements of specific relevance to the consumer healthcare industry such as MHRA guidance, international developments and Government updates to legislation, guidance and advice.
PAGB also offers a regulatory consultancy service to companies seeking early advice; for example, on the viability of bringing a product to market, seeking to reclassify a product or exploring claims. Contact us about our regulatory and advertising consultancy services.
To be granted a Marketing Authorisation (MA) or a traditional herbal registration (THR), the applicant company has to provide sufficient evidence to prove to MHRA that the product meets all the necessary requirements. Products may also be granted a MA through a European route which can allow a medicine to be launched into more than one Member State.